Evidence for noradrenergic mediation of opioid effects on luteinizing hormone secretion.
D000818:Animals; D005406:Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide / Q000494:pharmacology; D002369:Castration; D003000:Clonidine / Q000494:pharmacology; D004050:Ditiocarb / Q000494:pharmacology; D004958:Estradiol / Q000494:pharmacology*; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000378:metabolism*; D007031:Hypothalamus / Q000187:drug effects / Q000378:metabolism*; D007700:Kinetics; D007986:Luteinizing Hormone / Q000378:metabolism*; D009020:Morphine / Q000494:pharmacology*; D009270:Naloxone / Q000494:pharmacology*; D010643:Phenoxybenzamine / Q000494:pharmacology; D011374:Progesterone / Q000494:pharmacology*; D051381:Rats
D010643:Phenoxybenzamine; D005406:Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; D007987:Gonadotropin-Releasing Hormone; D009270:Naloxone; D011374:Progesterone; D004958:Estradiol; D009020:Morphine; D007986:Luteinizing Hormone; D004050:Ditiocarb; D003000:Clonidine